Question · asked by 1 review
Digital technology (TIM) vs standard treatment (TBM): Pulmonary exacerbations
- Population
- children aged 5 to 16 years
- Intervention
- Digital technology (TIM)
- Comparison
- standard treatment (TBM)
- Outcome
- Pulmonary exacerbations
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Digital technology (TIM) vs standard treatment (TBM) Number of pulmonary exacerbations · children aged 5 to 16 years The review found no eligible studies for this question. Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis (2023) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.